Is a complete DRTS research report available?

No complete published report is available for Alpha Tau Medical Ltd. (DRTS) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Alpha Tau Medical Ltd. (DRTS)

NASDAQ: DRTS · USD

$11.9

+0.71 (+6.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first DRTS analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1.1B
Net income (ttm)	-56.9M
EPS (ttm)	-$0.67
Shares out	90.3M
Volume	606,126
Beta	1.17
Price target	$14.2	+19.4%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -56.9M
EPS (ttm): -$0.67
Market cap: 1.1B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All DRTS indicators

Market & fundamental data

Available fields

187

Groups with data

Currency

USD

Showing 187 of 187 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001871321
Company name	Alpha Tau Medical Ltd.
Country	Israel
Country code	US
Cusip	M0740A108
Employees	121
Employees Change	-4%
Employees Change Percent	-3.2
Enterprise value	$1B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	IL0011839383
Last refreshed	2026-07-31
Market cap	$1.1B
Market cap category	Small-Cap
Price	$11.89
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	3841
Symbol	DRTS
Website	https://www.alphatau.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.3%
EV Sales Forward	397.55x
FCF yield	-3.05%
P/B ratio	15.46x
PS Forward	421.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-56.9M
Net Income Growth Years	0%
Profit Per Employee	$-470,041
ROA	-30.5
Roa5y	-22.65
ROCE	-47.08
ROE	-90.51
Roe5y	-48.67
ROIC	-37.99

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	310.4%
Cagr3y	45.87%
Cagr5y	3.9%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$108.8M
Cash	$76.4M
Current Assets	$81.3M
Current Liabilities	$10.4M
Debt	$14.3M
Debt Equity	$0.21
Equity	$69.4M
Interest Coverage	-4.64
Liabilities	$39.4M
Long Term Assets	$27.4M
Long Term Liabilities	$29M
Net Cash	$62.1M
Net Cash By Market Cap	$5.78
Net Cash Growth	57.79%
Net Debt Equity	$-0.9
Tangible Book Value	$69.4M
Tangible Book Value Per Share	$0.77
WACC	11.28

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.79
Net Working Capital	$-4.3M
Quick ratio	7.31
Working Capital	$70.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-21.8%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	310%
200-day SMA	7.48
3Y total return	210.44%
50-day SMA	11.2
50-day SMA vs 200-day SMA	50over200
5Y total return	21.08%
All Time High	20.65
All Time High Change	-42.42%
All Time High Date	2022-03-24
All Time Low	1.75
All Time Low Change	579.43%
All Time Low Date	2024-06-27
ATR	0.89
Beta	1.17
Beta1y	1.99
Beta2y	0.98
Ch YTD	140.2
High	11.95
High52	14.11
High52 Date	2026-07-06
High52ch	-15.73%
Low	11.3
Low52	2.87
Low52 Date	2025-07-31
Low52ch	314.29%
Ma50ch	6.13%
Premarket Change Percent	0.09
Premarket Price	$11.19
Premarket Volume	9,000
Price vs 200-day SMA	59.02%
RSI	49.17
RSI Monthly	77.08
RSI Weekly	65.57
Sharpe ratio	2.14x
Sortino ratio	3.87
Total Return	-21.8%
Tr YTD	140.2
Tr1m	5.97%
Tr1w	-10.2%
Tr3m	61.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	1
Analyst Price Target Top	$9
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.14
Earnings Revenue Estimate	230,136x
Operating Income	$-46.3M
Price target	$14.2
Price Target Change	$19.43
Price Target Change Top	$-24.31

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	62,094,135%
Float Percent	68.74%
Shares Insiders	15.24%
Shares Institutions	4.81%
Shares Out	90,325,876
Shares Qo Q	4.11%
Shares Yo Y	21.8%
Short Float	4.8%
Short Ratio	3.7
Short Shares	3.3

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-43.4M
Adjusted OCF	-37,298,000
Average Volume	738,332.95x
Bv Per Share	0.77
CAPEX	$-6.1M
Ch1m	5.97
Ch1w	-10.2
Ch1y	310
Ch3m	61.33
Ch3y	210.4
Ch5y	21.08
Ch6m	64.23
Change	6.35%
Change From Open	4.21
Close	11.18
Days Gap	2.06
Depreciation Amortization	1,264,500
Dollar Volume	7,206,838.1
Earnings Date	2026-08-12
Earnings Time	amc
EBIT	$-46.3M
EBITDA	$-46.3M
EPS	$-0.67
F Score	2
FCF	$-32.8M
FCF EV Yield	-3.24x
FCF Per Share	$-0.36
Financing CF	45,768,000
Fiscal Year End	December
Founded	2,015
Income Tax	$11,000
Investing CF	-20,588,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-18
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-09
Ma150	8.59
Ma150ch	38.35%
Ma20	12.64
Ma20ch	-5.94%
Net CF	-1,522,000
Next Earnings Date	2026-08-10
Open	11.41
Optionable	Yes
Position In Range	90.77
Post Close	11.89
Postmarket Change Percent	0.5
Postmarket Price	$11.95
Ppne	26,963,000
Pre Close	11.18
Price Date	2026-07-30
Ptbv Ratio	15.49
Relative Volume	0.82x
Share Based Comp	10,617,000
Tr6m	64.23%
Volume	606,126

Alpha Tau Medical Ltd. (DRTS)

Coverage state: Market snapshot only — no published research

Generate the first DRTS analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · DRTS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All DRTS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on DRTS

Frequently asked questions